Global Healthy Living Foundation Brings Innovative and Patient-Centered Polymyalgia Rheumatica, Psoriatic, and Rheumatoid Arthritis Research to ACR Convergence 2024
Twelve poster presentations with PatientSpot/GHLF involvement also accepted.
6 Common Myths About Hidradenitis Suppurativa (HS) That May Harm Patients
Myths about hidradenitis suppurativa (HS) may be harmful to those who suspect they may have it or who are already living with it. Get the facts about this chronic skin condition.
Popular ArthritisPower® Patient Registry Expands Conditions and Becomes PatientSpot™
UPPER NYACK, N.Y.--(BUSINESS WIRE) — ArthritisPower, leading arthritis patient registry, expands to PatientSpot, an omni-disease app as Class 1 FDA Medical Device.
Byzantine State Regulations Delay Vaccine Access at Pharmacies, Study Reveals
UPPER NYACK, N.Y.--(BUSINESS WIRE)--A groundbreaking study titled “Removing Barriers to Pharmacy Vaccination: A Path to Better Health and Lower Health Care Costs” has uncovered a tangled web of regulations preventing pharmacists from efficiently providing vaccines to adult patients.
Exciting News for Migraine Patients: American Headache Society Recommends CGRP-Targeting Therapies as a First-Line Treatment
The American Headache Society's latest guidance recommends CGRP therapies as a first-line treatment for preventing migraine.
The Truth About Drug Costs: How Pharmacy Benefit Managers Put Profits Before Patients
GHLF asked HSS to take definitive action to ensure that access to pharmacy services will remain when the current public health emergency formally ends.
New Study Shows Increase in Pharmacy Reimbursement Leads to Higher Adult Medicaid Flu Vaccination Rates
UPPER NYACK, N.Y.--(BUSINESS WIRE)--ESI and CVS Health continue to expose hundreds of thousands of patients to the risks of taking medicines their doctor did not prescribe, according to an existing peer-reviewed and updated study, and new research by the Global Healthy Living Foundation (GHLF).
Ensuring Equity in Inflammatory Bowel Disease (IBD) Care for LGBTQ+ People
Exploring the unique challenges faced by LGBTQ+ people with IBD and ways to create more equitable, inclusive health care environments for better health outcomes.
Navigating IBD and LGBTQ+ Identity: Krys Baxter’s Diagnosis Journey
In honor of Hispanic Heritage Month, we highlight the resilience and advocacy of Valerie, a beacon of hope in our patient community.
FDA Approves Zepbound for Obesity
Learn more about the FDA approval of new drug, Zepbound (tripeptide), for the treatment of adults with obesity.